Core Viewpoint - Jiangsu Kangzhong Digital Medical Technology Co., Ltd. has announced the first grant of stock options to incentive objects, with a total of 4 million stock options to be granted at an exercise price of 42.38 yuan per share, effective from February 12, 2026 [1][4][6]. Summary by Sections Incentive Plan Details - The stock option incentive plan was approved by the board on February 12, 2026, and involves granting 4 million stock options to 50 qualified incentive objects [1][4]. - The exercise price for the stock options is set at 42.38 yuan per share [9]. Decision-Making Process - The decision-making process included multiple board meetings and a public notice period from January 13 to January 22, 2026, during which no objections were raised [2][3]. - The board confirmed that all necessary approvals and disclosures were completed prior to the grant [2][25]. Eligibility Criteria - The board confirmed that both the company and the incentive objects met all eligibility criteria as outlined in relevant regulations, including no recent disqualifications or legal issues [3][5][17]. - The incentive objects include company directors, senior management, core technical personnel, and other key employees, excluding independent directors [18]. Accounting Treatment and Performance Impact - The accounting treatment for the stock options will follow the guidelines set forth in the relevant accounting standards, with the fair value of the options determined using the Black-Scholes model [20][23]. - The implementation of this incentive plan is expected to positively impact the company's operational performance by enhancing employee motivation and efficiency [24][25].
江苏康众数字医疗科技股份有限公司关于向激励对象首次授予股票期权的公告